I. Martynkevich

发表

Primary myelofibrosis: own experience and news from diagnostic and treatment

K. Abdulkadyrov, V. Shuvaev, I. Martynkevich, 2015 .

Molecular Genetic Markers and Clinical Characteristics of Essential Thrombocythemia

Fominykh, K. Abdulkadyrov, V. Shuvaev, 2017 .

[Cytogenetic profile in patients with primary myelodysplastic syndrome].

V. I. Aksenova, K. Abdulkadyrov, E. Petrova, 2013, Terapevticheskii arkhiv.

Clinical features and outcomes in chronic myeloid leukemia with T 315 I mutation

B. Afanasyev, A. Turkina, V. Shuvaev, 2017 .

[Aberrant methylation of the promoter regions of the SOX7 and p15INK4b genes and Wnt signaling pathway antagonists in patients with acute myeloid leukemias].

I. Martynkevich, S. Bessmeltsev, S. Gritsaev, 2016, Terapevticheskii arkhiv.

Chronic Myeloid Leukemia: Long-Term Experience of Target Therapy

Fominykh, K. Abdulkadyrov, E. Petrova, 2016 .

National clinical recommendations for the diagnosis and treatment of mastocytosis

A. Sudarikov, A. Kovrigina, V. Savchenko, 2021, Russian journal of hematology and transfusiology.

Hematological Improvement is a Favorable Response to Azacitidine in Patients with Acute Myeloid Leukemias and Myelodysplastic Syndromes

K. Abdulkadyrov, I. Martynkevich, I. Kostroma, 2015 .

Chronic Lymphocytic Leukemia: Prognostic Significance of Minimal Residual Disease and Potential of Modern Methods of Its Diagnosis and Therapy (Literature Review)

K. Abdulkadyrov, I. Martynkevich, S. Voloshin, 2016 .

[Transformation of secondary myelodysplastic syndrome to atypical chronic myeloid leukemia in a female patient with acute myeloid leukemia].

I. Martynkevich, S. Gritsaev, I. Kostroma, 2016, Terapevticheskii arkhiv.

Efficacy Predictors of the Third-Line Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Phase of Chronic Myeloid Leukemia: Results of a Multi-Center Study

A. Zaritskey, N. Medvedeva, S. Voloshin, 2022, Clinical oncohematology.

Withdrawal Syndrome After Tyrosine Kinase Inhibitor Discontinuation in Patients With Chronic Myeloid Leukemia in the Russian Prospective Study RU-SKI.

G. Gusarova, H. Julhakyan, A. Turkina, 2019, Clinical lymphoma, myeloma & leukemia.

The combination treatment regimen of ruxolitinib with low‐dose mercaptopurine or cytarabine in frail patients with blast‐phase myelofibrosis

K. Abdulkadyrov, V. Shuvaev, I. Martynkevich, 2017, British journal of haematology.

A prospective study of the monitoring of patients with chronic myeloid leukemia upon withdrawal of tyrosine kinase inhibitor therapy

G. Gusarova, A. Sudarikov, V. Savchenko, 2020, Russian journal of hematology and transfusiology.

Atypical Chronic Myeloid Leukemia Challenge in Russian Hematology Practice

V. Shuvaev, I. Martynkevich, L. Polushkina, 2018, Blood.

[The specific features of diagnosis of mixed-phenotype acute leukemia: A combination of B-cell antigen expressions according to the results of flow cytometry and morphological markers of myeloid differentiation in blast cells: A clinical case].

K. Abdulkadyrov, I. Martynkevich, N. Potikhonova, 2015, Terapevticheskii arkhiv.

National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)

B. Afanasyev, A. Sudarikov, A. Kovrigina, 2021 .

Efficacy of Tyrosine Kinase Inhibitors in Third Line Therapy in Chronic Phase Chronic Myeloid Leukemia

K. Abdulkadyrov, A. Zaritskey, V. Shuvaev, 2015 .

Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experience

S. Voloshin, V. Shuvaev, I. Martynkevich, 2023, Frontiers in Oncology.

PB2232 THE NATURAL ANTICOAGULANTS IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

V. Shuvaev, I. Martynkevich, L. Polushkina, 2019, HemaSphere.

Targeted Therapy of Myelofibrosis

Fominykh, O. Vinogradova, V. Shuvaev, 2017 .

Transcription of WNT Genes in Hematopoietic Niche’s Mesenchymal Stem Cells in Multiple Myeloma Patients with Different Responses to Treatment

N. Enukashvily, I. Martynkevich, S. Sidorkevich, 2023, Genes.

Significance of Modified Risk Stratification Msmart 3.0 and Autologous Stem Cell Transplantation for Patients with Newly Diagnosed Multiple Myeloma

V. Shuvaev, I. Martynkevich, S. Voloshin, 2019, Blood.

Prognostic Value of Genetic Mutations in Patients with Acute Myeloid Leukemias: Results of a Cooperative Study of Hematology Clinics of Saint Petersburg (Russia) and Charite Clinic (Germany)

I. Martynkevich, E. Karyagina, L. Martynenko, 2019, Clinical oncohematology.

Withdrawal Syndrome After Tyrosine Kinase Inhibitor Discontinuation in Patients With Chronic Myeloid Leukemia in the Russian Prospective Study RU-SKI.

G. Gusarova, H. Julhakyan, A. Turkina, 2019, Clinical lymphoma, myeloma & leukemia.

Current Genetic Models for Prediction of Primary Myelofibrosis

Fominykh, V. Shuvaev, I. Martynkevich, 2019, Clinical oncohematology.